Stock of the Day

March 3, 2021

Globe Life (GL)

$172.59
-$0.20 (-0.1%)
Market Cap: $13.28B

About Globe Life

Globe Life Inc., through its subsidiaries, provides various life and supplemental health insurance products, and annuities to lower middle- and middle-income families in the United States. The company operates in four segments: Life Insurance, Supplemental Health Insurance, Annuities, and Investments. It offers whole, term, and other life insurance products; Medicare supplement and supplemental health insurance products, such as accident, cancer, critical illness, heart, and intensive care plans; and single-premium and flexible-premium deferred annuities. The company sells its products through its direct to consumer division, exclusive agencies, and independent agents. The company was formerly known as Torchmark Corporation and changed its name to Globe Life Inc. in August 2019. Globe Life Inc. was founded in 1900 and is headquartered in McKinney, Texas.

Today's Trend

Globe Life Inc. (NYSE: GL) is trading higher overall after a busy earnings day that included both a profit miss and several signals that analysts still see upside. The stock appears to be getting support from upbeat analyst commentary and management’s raised 2026 outlook, even though investors were disappointed by softer sales and higher expenses.

  • Keefe, Bruyette & Woods trimmed its price target only modestly to $190 from $192 and kept an outperform rating, implying roughly 9% upside from recent levels. Benzinga article
  • TD Cowen also reiterated a bullish view, forecasting strong price appreciation for Globe Life (GL). American Banking News article
  • Management raised its 2026 net operating EPS guidance to $15.55-$15.95 and lifted share repurchases to $670 million-$700 million, signaling confidence in future earnings and capital returns. Seeking Alpha article
  • Globe Life’s Q2 revenue came in roughly in line with expectations, and underwriting income remained strong, showing the core business is still performing acceptably despite some headwinds. Reuters article
  • Q2 earnings of $3.61 per share missed the consensus estimate of $3.67, and several reports pointed to softer sales and rising expenses as reasons for investor concern. MSN article

Overall, Globe Life (GL) looks like a stock being pulled in two directions: near-term pressure from the earnings miss and weak sales, offset by upbeat analyst views, strong underwriting performance, and an improved outlook with more buybacks.

Recent News